[Found at http://www.thespec.com/News/Local/article/524206 so I guess this will help us get rid of those asthmatic people faster when they start to take this nice new drug that will lower their white blood cells so they can get sick much easiler. Maybe even die because of this. LIFEKILLS working over time again. Interesting read I wonder if they are not just using those people as test subject and when the time comes they will spray this over the mass via chem trail to lower all our white blood cell count so then they can get us with the real deal.]
The Hamilton Spectator(Mar 5, 2009)
Severe asthmatics could well breath easier with a new drug being tested in Hamilton.
[Of coruse they want you to breath easier so you can breath in all the chem trail they will be spraying over their head]
Mepolizumab appears to reduce the number of white blood cells called eosinophils,
[Eosinophil granulocytes, usually called eosinophils (or, less commonly, acidophils), are white blood cells that are one of the immune system components responsible for combating infection and parasites in vertebrates. taken from Wikipedia]
which are associated with asthma. That means patients can reduce their use of other medications such as corticosteroids, which have side effects particularly when used long term.
The McMaster study by Param Nair, being published in the New England Journal of Medicine today, found the nine patients who received mepolizumab for five months "markedly reduced" their use of corticosteroid prednisone. In contrast, the 11 asthmatics given a placebo had flare-ups if they used less medication.
About 5 to 8 per cent of asthmatics or an estimated 60,000 to 120,000 Canadians have severe enough asthma to possibly benefit from monthly injections of mepolizumab, which is an antibody. The drug is not yet approved in Canada.
The Hamilton Spectator(Mar 5, 2009)
Severe asthmatics could well breath easier with a new drug being tested in Hamilton.
[Of coruse they want you to breath easier so you can breath in all the chem trail they will be spraying over their head]
Mepolizumab appears to reduce the number of white blood cells called eosinophils,
[Eosinophil granulocytes, usually called eosinophils (or, less commonly, acidophils), are white blood cells that are one of the immune system components responsible for combating infection and parasites in vertebrates. taken from Wikipedia]
which are associated with asthma. That means patients can reduce their use of other medications such as corticosteroids, which have side effects particularly when used long term.
The McMaster study by Param Nair, being published in the New England Journal of Medicine today, found the nine patients who received mepolizumab for five months "markedly reduced" their use of corticosteroid prednisone. In contrast, the 11 asthmatics given a placebo had flare-ups if they used less medication.
About 5 to 8 per cent of asthmatics or an estimated 60,000 to 120,000 Canadians have severe enough asthma to possibly benefit from monthly injections of mepolizumab, which is an antibody. The drug is not yet approved in Canada.
No comments:
Post a Comment